Selected Highlights from the 7th Conference on Retroviruses and Opportunistic Infections

• Introduction
• Experimental Drugs
• Combination Drug Studies
• Drug Interaction and Side Effect Studies
• Studies of Switching Therapy
• Miscellaneous

Introduction

Approximately 3,200 physicians and researchers attended the 7th Conference on Retroviruses and Opportunistic Infections (CROI) held January 30-February 2, 2000, in San Francisco. The annual CROI is the most important conference held in North America that addresses clinical and basic science research in HIV/AIDS. Nearly one-third of attendees were from outside the U.S., and more than 855 abstracts were accepted for oral or poster presentation.

Topics covered clinical drug trials, research about HIV treatments, side effects and strategies, tests for diagnosis and management of HIV infection, therapeutic and preventive vaccines, opportunistic infections (OIs) and cancers, immunology, molecular virology, epidemiology (population-based studies about HIV transmission and prevention), drug adherence, special populations (infants/children, racial/ethnic minorities, women, people in developing countries), and selected topics on economic and social/psychosocial issues. Reflecting the trend in the pandemic, there were fewer presentations about OIs than during past CROIs.

The 7th CROI was sponsored by the Foundation for Retrovirology and Human Health in scientific collaboration with the U.S. Centers for Disease Control and Prevention (CDC) and the National Institute of Allergy and Infectious Diseases (NIAID). There were 116 full travel scholarships for young scientific investigators. Also, 50 partial or full scholarships were provided for community representatives. Abstracts, plenary sessions (audiovisual), and posters are available online for one year at www.retroconference.org.

Note that all references are from the 7th CROI.

Back to the SFAF BETA Spring, 2000 contents page.